REG - Iconic Labs PLC - Conversion of Notes

Iconic LabsAnnouncement

06/02/2023 07:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230206:nRSF0040Pa&default-theme=true

RNS Number : 0040P  Iconic Labs PLC  06 February 2023

Iconic Labs PLC

 

("Iconic" or the "Company")

 

Conversion of Notes

 

 

 

Iconic Labs PLC (LSE:ICON), a multi-divisional new media and technology
business, announces that it has received a valid Conversion Notice from the
European High Growth Opportunities Securitization Fund ("EHGOSF").

 

Conversion of Loan Notes

The Conversion Notice was dated 2 February 2023 and provides for 100
Convertible Notes to be converted into 1,234,567,901 ordinary shares of
£0.00001 ("Ordinary Shares") in the Company at a conversion price of
£0.000081 at the aggregate principal amount of £100,000.

Application is being made for the 1,234,567,901 new Ordinary Shares to be
admitted to trading on the Main Market of the London Stock Exchange which is
expected to be on or around 9 February 2023. These shares rank pari passu
with the existing Ordinary Shares of the Company.

Following the issue of these shares, the Company's issued ordinary share
capital shall consist of 40,898,270,045 Ordinary Shares. The figure of
40,898,270,045 represents the total voting rights in the Company and should be
used by shareholders as the denominator for the calculation by which they can
determine if they are required to notify their interest in, or a change to
their interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance & Transparency Rules.

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic
law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is
disclosed in accordance with the Company's obligations under Article 17 of
MAR.

 

For any further information or enquiries please contact:

 

ir@iconiclabs.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CONFIFLDFRIRIIV